Metabolic dysfunction-associated steatotic liver disease and cardiovascular pathology
Open Access
- 20 September 2026
- journal article
- Published by ECO-Vector LLC (Publications) in Perm Medical Journal
- Vol. 43 (4) , 5-19
Abstract
The data on the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and its phenotypes, the evolution of steatotic liver disease terminology and its association with cardiovascular diseases were summarized. A systematic search for relevant publications in the PubMed database was performed. MASLD has become one of the most prevalent and underappreciated cardiovascular threats. It is closely associated with the development and progression of atherosclerotic cardiovascular diseases, arrhythmias, conduction disorders, hypertension and heart failure. Moreover, MASLD is a crucial part of the cardiohepatorenal continuum. Raising awareness of MASLD among the general public and at-risk populations, unifying existing guidelines for cardiometabolic diseases, and the development of regional and global strategies to combat MASLD are essential to tackle the cardiometabolic pandemic.Keywords
This publication has 67 references indexed in Scilit:
- Global prevalence, metabolic characteristics, and outcomes of lean-MAFLD: a systematic review and meta-analysisHepatology International, 2025
- Liver and cardiovascular outcomes in lean non-alcoholic fatty liver disease: an updated systematic review and meta-analysis of about 1 million individualsHepatology International, 2024
- Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysisWorld Journal of Pediatrics, 2024
- Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysisCurrent Problems in Cardiology, 2023
- A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2022
- Association of Non-Alcoholic Fatty Liver Disease With in-Hospital Outcomes in Primary Heart Failure Hospitalizations With Reduced or Preserved Ejection FractionCurrent Problems in Cardiology, 2022
- Association of Liver Fibrosis Risk Scores with Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Findings from TOPCATESC Heart Failure, 2021
- The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failureHeart and Vessels, 2017
- Effect of Nonalcoholic Fatty Liver Disease on In-Hospital and Long-Term Outcomes in Patients With ST–Segment Elevation Myocardial InfarctionThe American Journal of Cardiology, 2017
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015